Literature DB >> 31420806

Prognostic four-gene signature for overall survival in patients with hepatocellular carcinoma.

Tatsuo Kanda1, Osamu Yokosuka2, Mitsuhiko Moriyama3.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2019        PMID： 31420806     DOI： 10.1007/s12072-019-09976-x

Source DB:  PubMed          Journal:  Hepatol Int        ISSN： 1936-0533            Impact factor:   6.047


× No keyword cloud information.
  11 in total

Review 1.  Claspin - checkpoint adaptor and DNA replication factor.

Authors:  Veronique A J Smits; Elisa Cabrera; Raimundo Freire; David A Gillespie
Journal:  FEBS J       Date:  2018-06-29       Impact factor: 5.542

2.  Association of des-γ-carboxy prothrombin production and Sonazoid-enhanced ultrasound findings in hepatocellular carcinomas of different histologic grades.

Authors:  Kazumoto Murata; Akiko Saito; Satoshi Katagiri; Shunichi Ariizumi; Masayuki Nakano; Masakazu Yamamoto
Journal:  J Med Ultrason (2001)       Date:  2017-08-21       Impact factor: 1.314

3.  PBK overexpression promotes metastasis of hepatocellular carcinoma via activating ETV4-uPAR signaling pathway.

Authors:  Qiu-Xia Yang; Shan Zhong; Lin He; Xiao-Jiong Jia; Hua Tang; Sheng-Tao Cheng; Ji-Hua Ren; Hai-Bo Yu; Li Zhou; Hong-Zhong Zhou; Fang Ren; Zhong-Wen Hu; Rui Gong; Ai-Long Huang; Juan Chen
Journal:  Cancer Lett       Date:  2019-03-23       Impact factor: 8.679

4.  Serum miRNA-based Prediction of Axillary Lymph Node Metastasis in Breast Cancer.

Authors:  Sho Shiino; Juntaro Matsuzaki; Akihiko Shimomura; Junpei Kawauchi; Satoko Takizawa; Hiromi Sakamoto; Yoshiaki Aoki; Masayuki Yoshida; Kenji Tamura; Ken Kato; Takayuki Kinoshita; Yuko Kitagawa; Takahiro Ochiya
Journal:  Clin Cancer Res       Date:  2018-11-27       Impact factor: 12.531

5.  PDZ binding kinase, regulated by FoxM1, enhances malignant phenotype via activation of β-Catenin signaling in hepatocellular carcinoma.

Authors:  Yu-Feng Yang; Ying-Hua Pan; Yun Cao; Jia Fu; Xia Yang; Mei-Fang Zhang; Qiu-Hong Tian
Journal:  Oncotarget       Date:  2017-07-18

Review 6.  Exosomes and Hepatocellular Carcinoma: From Bench to Bedside.

Authors:  Reina Sasaki; Tatsuo Kanda; Osamu Yokosuka; Naoya Kato; Shunichi Matsuoka; Mitsuhiko Moriyama
Journal:  Int J Mol Sci       Date:  2019-03-20       Impact factor: 5.923

7.  CBX2 Regulates Proliferation and Apoptosis via the Phosphorylation of YAP in Hepatocellular Carcinoma.

Authors:  Jiakai Mao; Yu Tian; Chengye Wang; Keqiu Jiang; Rui Li; Yifan Yao; Rixin Zhang; Deguang Sun; Rui Liang; Zhenming Gao; Qi Wang; Liming Wang
Journal:  J Cancer       Date:  2019-06-02       Impact factor: 4.207

8.  Clinical significance of glypican-3-positive circulating tumor cells of hepatocellular carcinoma patients: A prospective study.

Authors:  Michinori Hamaoka; Tsuyoshi Kobayashi; Yuka Tanaka; Hiroaki Mashima; Hideki Ohdan
Journal:  PLoS One       Date:  2019-05-29       Impact factor: 3.240

9.  TopBP1 and Claspin contribute to the radioresistance of lung cancer brain metastases.

Authors:  Seung Ho Choi; Heekyoung Yang; Seung Ho Lee; Joo-Hyun Ki; Do-Hyun Nam; Hae Yong Yoo
Journal:  Mol Cancer       Date:  2014-09-12       Impact factor: 27.401

10.  MicroRNA-107: a novel promoter of tumor progression that targets the CPEB3/EGFR axis in human hepatocellular carcinoma.

Authors:  Chen-Dan Zou; Wei-Ming Zhao; Xiao-Na Wang; Qiang Li; Hui Huang; Wan-Peng Cheng; Jian-Feng Jin; He Zhang; Ming-Juan Wu; Sheng Tai; Chao-Xia Zou; Xu Gao
Journal:  Oncotarget       Date:  2016-01-05
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.